Please login to the form below
legal action
This page shows the latest legal action news and features for those working in and with pharma, biotech and healthcare.
Pfizer and BioNTech speak out against CureVac suit over patents for COVID-19 vaccines
Both BioNTech and Pfizer assert that following CureVac’s failed attempts to develop a COVID-19 vaccine, CureVac tried to profit from the partnership, threatening patent infringement and legal action as
Latest news
-
Enanta takes legal action against Pfizer over Paxlovid patent infringement
The company gave a statement in which it said it “recognises the importance of Paxlovid’s availability to patients and does not intend to seek an injunction or take other action ... Despite acknowledging the potential for disruption in Paxlovid’s
-
Teva reaches $925,000 settlement to resolve drug price-fixing claims
The legal action was filed by Connecticut Attorney General William Tong and follows a five-year investigation into the alleged conspiracy to fix prices and allocate markets for more than 100
-
Court rules on AZ and EU’s COVID-19 vaccine dispute
In its legal action against AZ, the EC had requested 120 million vaccine doses cumulatively by the end of June 2021, and a total of 300 million doses by the end ... It also demonstrates, that it was founded on a sound legal basis,” she added.
-
EU asks AZ to deliver 120 million COVID-19 vaccines by the end of June
Initially, the European Commission moved forward with legal action against AZ in April on the basis that terms of the contract “have not been respected”, according to EC spokesperson Stefan De
-
EU moves forward with legal action against AZ over vaccine supply issues
The European Commission (EC) is moving forward with legal action against AstraZeneca (AZ) over delays of the company’s COVID-19 vaccine to the EU. ... Spokesperson Stefan De Keersmaeker commented: “On Friday the Commission started legal action
More from news
Approximately 9 fully matching, plus 66 partially matching documents found.
Latest Intelligence
-
Five things you didn't realise you already know about influencer marketing
In some cases these bodies have even brought legal action. Although it might seem daunting, the strict climate of compliance in the pharma industry means this may not be the hurdle
-
Macron, Merkel and May: implications of the 2017 elections for the life science industry
The ABPI has pursued legal action, arguing that this contravenes the NHS Constitution, which legally entitles patients access to NICE-approved treatments.
-
Intellectual property threats in the BRIC markets
of the compulsory licence process for Herceptin, Sprycel and Ixempra, revocation of a patent for Pfizer's Sutent and a legal ruling allowing a generic version of Tarceva. ... This interpretation would support the traditional response of the industry,
-
Pharma deals during July 2012
As is usual in the US, one shareholder has already started legal action against the deal saying the price is too low and a competitive bidding process has been avoided.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Article: The Colombia Conundrum
Challenges. For treatments that fall outside of these schemes, there is an alternative route patients can go down to attempt to access them: legal action, via ‘recobros’.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- ONS data reveals significant decrease in COVID-19 antibodies
- Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies
- UK government’s ‘science superpower’ ambitions to fail without clear plan, Lords committee warns
- WHO releases interim statement on COVID-19 vaccination for children and adolescents
- Novartis reports death of two patients treated with Zolgensma
- The impact of COVID-19 on the fight against AMR
- NHS bowel cancer checks reach record-high following death of Dame Deborah James
- Environment: where does the pharmaceutical industry stand?
- Moderna’s Omicron booster receives MHRA approval
- Sanofi halts recruitment for trials assessing MS treatment
- BeiGene announces positive phase 3 trial results for liver cancer treatment
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- A creative awakening – how pharma is bringing innovation to the patient journey
- Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
PMHub
Research Partnership
Research Partnership is now a member of Inizio Advisory, the consulting business unit of Inizio, a strategic partner for health...
Latest intelligence
- Environment: where does the pharmaceutical industry stand?
- ...
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
